A pair of Rutgers professors have partnered with a former colleague to form a startup with the goal of developing novel cancer treatments based on the use of antibody drug conjugates.
It’s been a record year for innovation at Rutgers University, and for the Innovation Ventures (now Technology Transfer) team in the Office for Research, despite the challenges and new reality that came with the COVID-19 pandemic. Even limited access to laboratories, countless Zoom meetings, and the burnout many experienced over the past year could not stop the Rutgers Research and Innovation engine.
As a key player in developing and transforming innovators into entrepreneurs that improve people’s lives, Rutgers, The State University of New Jersey will expand its entrepreneurship training programming and further equip faculty and student researchers with the skills and strategy needed to transition their discoveries into technologies and products, as a partner in the newly created NSF I-Corps™ Hub: Northeast Region.
A company founded by Rutgers School of Dental Medicine researcher received U.S. Food and Drug Administration approval to begin a phase I clinical trial to treat cancer patients with a therapy based on his discovery that a protein produced by an oral bacterium can kill leukemia and lymphoma cells.
Universities play an important role in inspiring diversity among new generations of entrepreneurs and innovators to improve the innovation ecosystem. Providing underrepresented researchers with access to opportunities and networks can bring the needed change to better reflect the diversity of our nation and to tip the scale toward equity and inclusion in innovation.
A mobile application developed by researchers Joel Caplan and Leslie Kennedy at Rutgers University aims to protect first responders and healthcare workers by identifying environmental factors that could be contagion vectors among COVID-19 positive cases.
Rutgers University and professional services company Accenture join efforts to solve the necessity of face shields and other personal protection equipment for healthcare workers and researchers on the front lines of the COVID-19 pandemic.